Watch: 13 people with Parkinson’s on the impact of exercise
Health & Fitness
Author: Saskia MairPublished: 21 May 2020
Prep: Cook: Serves:
“What are the benefits of exercise?” A new global video project sees people with Parkinson’s share how staying active has helped them manage their symptoms – and encourages others with the condition to join in
People with Parkinson’s around the world – from Wales to
Peru and Canada to New Zealand –share how exercise has impacted their life with
the condition in a new video project.
In ‘What are the benefits of exercise?’ and ‘What keeps you motivated?’, participants show their routines – from weightlifting and running, to cycling and boxing – discuss the challenges they’ve faced, and highlight the effects of regular exercise, which include improving balance and posture, and supporting mental health.
They also contribute fitness tips for those who struggle to form a workout habit. “Find what you enjoy and use that to keep yourself moving,” suggests John Reyes from the USA who was diagnosed with Parkinson’s aged 36, while Jonny Acheson from the UK, who was diagnosed aged 41, recommends setting “a goal or challenge – and if at first you don’t succeed, just keep trying”.
Video creator Christine Jeyachandran, who lives in Peru, was diagnosed with the condition aged 37 and took up gymnastics to help manage her symptoms. She says that the experience inspired her to organise the project.
that I’d go whether I felt like it or not. As I advanced and improved my range
of movement, it encouraged me to try harder things. I had to overcome apathy, doubts, fatigue and fear to get serious
about exercising – but the benefits have been worth the effort.”
Christine has also made a ‘Before and After’ video, demonstrating how her symptoms have improved since starting her exercise routine. But, she says, showcasing stories from people of different ages, with varying experiences, is essential to persuade others to keep fit.
“I didn’t want people to say: ‘I couldn’t do that – you are younger and less affected than me’. So, I asked if others had benefited from exercise, and the videos say it all. These stories communicate with people with Parkinson’s better than scientific studies.”
And, although many are confined to their homes during the
coronavirus pandemic, it’s still vital to keep moving.
“Society might be in lockdown, but Parkinson’s disease is
ongoing,” she says. “In these times, it is harder to keep self-motivated, and if
I don’t exercise my body stiffens up and dyskinesia increases.
“Being stuck in an apartment gets to me, but when I do my
abdominal workout I feel so much better.”
Exercise and Parkinson’s
Research indicates that exercise can be neuroprotective – meaning it can slow down the progression of Parkinson’s. It can also provide physiological benefits
Ask for professional medical advice to find activities that suit your fitness and mobility level
Include a mixture of stretching, strengthening, weight bearing and balance exercises, alongside aerobic activity
Make sure you warm up first, and don’t try to do too much too quickly
New wearable medical device for Parkinson’s disease to launch this year
The Imperial College London Innovation Fund, UK, has invested £205,000 to support UK-based tech company Charco Neurotech in its development of a non-invasive medical device for people with Parkinson’s disease. CUE1, a circular device that attaches to the sternum with medical adhesives, uses specialised vibration to help alleviate physical symptoms of Parkinson’s disease. Initial user testing among people with the condition found that the device improved movement by an average of 16%, with testers reporting benefits for walking and fine motor tasks. Lucy Jung, CEO and co-founder of Charco Neurotech, said: “We believe that CUE1 has the potential to significantly improve [Parkinson’s disease] symptoms through its unique controlled vibration technology. We are excited to continue our work on the device and we look forward to the outcome of our proposed clinical trials.” Charco Neurotech will use the Imperial College investment to initiate a clinical trial and fund the device’s manufacture for…
New study brings scientists a “vital step” closer to understanding Parkinson’s disease
A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”
Could a prostate drug lower the risk of Parkinson’s disease?
Researchers in the US, Denmark and China have found that a type of medication used to treat enlarged prostate, known as alpha-blockers, is associated with a lower risk of Parkinson’s disease. As part of the study, the research team analysed patient data from 150,000 men using medications like the alpha-blocker terazosin – which has previously been shown to slow Parkinson’s disease progression in animals – and compared their findings to data from 150,000 men using the alpha-blocker tamsulosin. They found that men taking terazosin were 12 to 37% less likely to develop Parkinson’s disease. Jacob Simmering, corresponding author of the study, said: “Despite the relative differences in population and health care system structure, we found a similar protective effect in both [the US and Denmark]. “If these results are confirmed through further investigation, especially a randomised clinical trial, terazosin may provide neuroprotection and potentially prevent – and not just manage…